Keywords: astrazeneca, hit, slip, losec, sales, says, first
AstraZeneca hit by slip in Losec sales
Article | 26 April 2001
AstraZeneca says that sales for the first quarter of 2001 increased 7%to $3.99 billion, while operating profit was 12% higher at $1.06 billion and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
